Toxische epidermale Nekrolyse nach Apalutamid mit vorheriger Gabe von Tislelizumab bei einem Patienten mit zwei Krebsarten.

Wu, Wenjie; Da, Meihong; Chen, Mei; Wang, Fengyuan; Wu, Yue; Du, Yaxin; Sun, Lin; Zhu, Xinyu; Wang, Fei

Wu, Wenjie; Da, Meihong; Chen, Mei; Wang, Fengyuan; Wu, Yue; Du, Yaxin; Sun, Lin; Zhu, Xinyu; Wang, Fei.

Afiliación

Wu W; Department of Dermatology, ZhongDa Hospital, School of Medicine, Southeast University, Nanjing, China.
Da M; Department of Dermatology, ZhongDa Hospital, School of Medicine, Southeast University, Nanjing, China.
Chen M; Department of Dermatology, ZhongDa Hospital, School of Medicine, Southeast University, Nanjing, China.
Wang F; Department of Dermatology, ZhongDa Hospital, School of Medicine, Southeast University, Nanjing, China.
Wu Y; Department of Dermatology, ZhongDa Hospital, School of Medicine, Southeast University, Nanjing, China.
Du Y; Department of Dermatology, ZhongDa Hospital, School of Medicine, Southeast University, Nanjing, China.
Sun L; Department of Dermatology, ZhongDa Hospital, School of Medicine, Southeast University, Nanjing, China.
Zhu X; Department of Dermatology, ZhongDa Hospital, School of Medicine, Southeast University, Nanjing, China.
Wang F; Department of Dermatology, ZhongDa Hospital, School of Medicine, Southeast University, Nanjing, China.

J Dtsch Dermatol Ges ; 21(10): 1221-1223, 2023 10.

Article en De | MEDLINE | ID: mdl-37845064

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: De Revista: J Dtsch Dermatol Ges Asunto de la revista: DERMATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Alemania

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google